Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sweden-based pharmaceutical company Medivir has announced that the FDA and European regulatory authorities have validated the new drug application and marketing authorization application for the company's Lipsovir.
Subscribe to our email newsletter
The authorities will start the review process to evaluate the data submitted by Medivir. The outcome of this review is expected to be received in the late part of the third quarter of 2009.
Lipsovir is a topical product for the prevention and treatment of cold sores. Lipsovir is a patented combination of hydrocortisone (an anti-inflammatory agent) and acyclovir (an antiviral agent) in a proprietary cream base developed by Medivir.